Democratic Republic of the Congo -- A million children immunized, Chechnya -- overcoming operational challenges, Malawi -- 10 years of antiretrovirals, Lebanon -- Healing invisible wounds
In July 2002, Fred MINANDI, one of MSF's first patients in Malawi to receive antiretroviral drugs (ARVs), spoke about his daily life at the 14th international conference on HIV/AIDS, held in Barcelona. At that time, donors refused to fund HIV/AIDS programs as they did not believe that African...
Martha HUCKABEE was head of mission in Malawi from June 2009 to December 2010. While patient treatment in Malawi has changed significantly over 10 years, the new World Health Organization (WHO) directives create new challenges – particularly financial ones. How will the new WHO recommendations...
Licenses just agreed between three generic manufacturers and pharmaceutical company Tibotec, owned by Johnson & Johnson, will keep a promising new AIDS medicine out of the hands of many patients across the developing world, the international medical humanitarian organisation Médecins Sans...
In 2010, international donors shifted their focus away from AIDS, threatening the advances that have been made in treating the disease over the last decade. New scientific evidence and treatment recommendations reinforce the need to provide people with better treatment and earlier during the...
In a move that could boost access to affordable medicines in the developing world, the Medicines Patent Pool was formally created in July 2010, and promptly received official backing from the US National Institutes of Health (NIH) two months later. MSF has been actively campaigning for the creation...
The Global Fund to Fight AIDS, Tuberculosis and Malaria has rejected ambitious proposals to turn back the AIDS epidemic in several high-burden sub-Saharan African countries. It has also decided to significantly delay the next opportunity for countries to apply for funding until December 2011, which...
HIV/AIDS treatment in developing countries is being dealt a double blow that will mean treatment recommendations cannot be implemented and the promise of new science remain unfulfilled, said the international medical humanitarian organisation Médecins Sans Frontières (MSF). “The price of the newer...
“Since the project started in 2003, the quality of medical care offered to HIV patients in Guangxi province has vastly improved, and this project is a good example of how such collaboration between China’s health authorities and an international medical organization like MSF can be beneficial for...
Backtracking by international donors in funding HIV/AIDS risks undermining years of positive achievements and will cause many more unnecessary deaths, warns humanitarian aid group Médecins Sans Frontières (MSF) in a new report. Titled “No time to quit: HIV/AIDS treatment gap widening in Africa”,...
